| INTRODUCTION
Kidneys have a great compensatory ability when affected by insults that could compromise their function. 1 As a consequence, conventional markers of renal disease, such as serum creatinine, often lead to late diagnosis of chronic kidney disease (CKD). 2 This makes it difficult and challenging for veterinarians to detect kidney disease at an early stage when proper treatment might slow CKD progression and improve longevity and quality of life. 3 Furthermore, while measurement of †
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Abbreviations: /c, creatinine ratio; BCS, body condition score; BW, body weight; CKD, chronic kidney disease; CRP, C-reactive protein; CV, coefficient of variation; ELISA, enzyme-linked immunosorbent assay; GFR, glomerular filtration rate; IgG, immunoglobulin G; LOD, limit of detection; LOQ, limit of quantification; MW, molecular weight; NGAL, neutrophil gelatinase-associated lipocalin; PENIA, particle-enhanced nephelometric immunoassay; RBP, retinolbinding protein; sCysC, serum cystatin C; SE, standard error; u, urinary; UPC, urinary protein:creatinine ratio; USG, urine specific gravity; VC, variance component glomerular filtration rate (GFR) is the gold standard to determine kidney function, the clinical application in veterinary medicine is cumbersome as multiple sampling is often required and filtration markers or specialized equipment to analyze the markers are not commercially available. 4 Therefore, there is a search for more sensitive markers of kidney disease and indirect markers of GFR in veterinary medicine.
Combined use of sensitive indirect markers of GFR and sitespecific (i.e., glomerular and tubular) markers of renal disease, allowing for earlier detection of CKD, could potentially offer veterinarians a powerful alternative, particularly in the context of routine screening or serial monitoring of individuals. Serum symmetric dimethylarginine is a more sensitive and specific indirect GFR marker when compared to creatinine. 5, 6 However, there are other markers that have potential to detect early renal dysfunction. Serum cystatin C (sCysC), for example, is a low molecular weight (MW) protein that meets many of the requirements for an ideal endogenous GFR marker. 7 Serum cystatin C is a better marker of GFR than serum creatinine and has good diagnostic accuracy in predicting CKD in humans. 8, 9 In dogs, sCysC has a comparable or better sensitivity to detect a decrease in GFR compared to serum creatinine. 7 However, it lacks specificity. 7 To our knowledge, there are no studies yet comparing sCysC directly to serum symmetric dimethylarginine in dogs.
Several site-specific urinary markers have also been investigated in recent years. C-reactive protein (CRP) and immunoglobulin G (IgG)
are both high MW proteins associated with glomerular damage when detected in urine. 10 Retinol-binding protein (RBP) and neutrophil gelatinase-associated lipocalin (NGAL) are both low MW proteins that reflect tubular damage. 10 These markers increase in dogs with CKD and some correlate to glomerular lesions, tubulointerstitial lesions, or both of differing magnitudes. [10] [11] [12] [13] Despite the potential of these markers, their use is still limited to research purposes. Generally accepted reference ranges and cut-off values do not exist yet due to lack of standardized methods of analysis and large-scale studies. Moreover, information on long-term variation of both healthy and diseased dogs is lacking for sCysC and urinary 
| MATERIALS AND METHODS
This longitudinal study of 1. 
| Animals
Eight healthy lean adult Beagles (three intact and one spayed female, two intact and two neutered males) were included in the study. during the entire study. The amount was adjusted weekly to maintain an ideal BW and BCS (4 -5/9), both of which were assessed weekly.
Water was provided ad libitum. Blood and urine samples were col- 
| Assays
Serum cystatin C was measured with particle-enhanced nephelometric immunoassay (PENIA) previously validated for dogs. 15, 16 Samples for sCysC were analyzed in four batches. The limit of detection (LOD)
of PENIA for sCysC was 0.05 mg/L. uRBP concentrations were analyzed with a commercially available human ELISA kit (Immunology Consultants Laboratory, Portland, OR, USA). uNGAL (BioPorto Diagnostics, Hellerup, Denmark), uIgG (Immunology Consultants Laboratory, Portland, OR, USA) and uCRP (Immunology Consultants Laboratory, Portland, OR, USA) concentrations were determined with commercial canine-specific ELISA kits. uRBP, uNGAL, uIgG and uCRP assays were previously validated for use with canine urine. 12, 17 All immunoassays were performed in two batches and were used according to manufacturer's instructions and performed as previously described. 12, [17] [18] [19] The LOD and limit of quantification (LOQ) were determined in previous studies. 17, 19 The LOD and LOQ of the uRBP, uNGAL, uIgG and uCRP assays were 14.11 ng/mL and 18.93 ng/mL, 5.35 pg/mL and 9.60 pg/mL, 19.69 ng/mL and 29.72 ng/mL and 5.28 ng/mL and 7.76 ng/mL, respectively. The concentration of each urinary marker was expressed as a ratio to urinary creatinine (/c) to account for variations in urine concentration. 18 Urinary creatinine was determined by the modified kinetic Jaffé method. 17 
| Statistical Analysis
Statistical analysis was performed with R (version 3. 
| RESULTS
During the study, percentage BW changes varied between -3.9% and 14.8% compared to week 0. BCS, however, remained within the ideal range (BCS 4 -5/9), as each unit increase is associated with a 10-15% change in weight on a 9-point scale. 21 One of the dogs had persistent mild proteinuria (UPC 0.62 AE 0.14) without azotemia from week 12.
In another dog euthanized after week 56 because of multicentric lymphoma, only the first 6 of the 8 time points were included for statistical analysis. All dogs had a serum creatinine concentrations less than The biological variance of sCysC was investigated a decade ago in healthy dogs. 22 Even with a longer study duration in the current study sCysC, serum cystatin C; uRBP/c, urinary RBP-to-creatinine ratio; uNGAL/ c, urinary NGAL-to-creatinine ratio; uIgG/c, urinary IgG-to-creatinine ratio. SD, within-dog standard deviation; CV, coefficient of variation; sCysC, serum cystatin C; uRBP/c, uRBP-to-creatinine ratio; uNGAL/c, uNGAL-to-creatinine ratio; uIgG/c, uIgG-to-creatinine ratio.
compare different studies and to establish generally applicable reference intervals that reflect exact sCysC concentrations. 7 Long-term variability of uCRP, uRBP, uNGAL and uIgG has not been previously assessed in dogs or in other companion animal species. Even in humans, data are scarce. Thus, this study is the first to demonstrate high variability over time of markers of kidney disease uRBP, uNGAL and uIgG. Yet, of the urinary markers evaluated, uRBP/c seems least prone to within-dog variability. RBP, a 21 kDa plasma protein, is freely filtered through the glomerulus in the unbound form, and in healthy animals mostly reabsorbed and catabolized in the proximal tubules. 23 The presence of RBP in urine occurs when tubules are injured, when abnormal amounts of proteins compete for reabsorption, or both. 10 An undetectable to a low uRPB/c of <0.15 mg/g is expected in healthy dogs. 10 The overall mean AE withindog SD from the current study (0.09 AE 0.01 mg/g) corroborates this finding and only one dog had a concentration below the LOD. Day-today CV of 9.2 to 10.5% occurs in humans. 24 The within-dog CV of the current study is much higher, possibly as a result of the longitudinal nature of the study. Nevertheless, the variation is still moderate compared to that of uIgG/c and uNGAL/c. Therefore, uRBP/c might still be potentially useful as urinary markers reflect lesions and physiology occurring in the kidneys more directly and might be a more sensitive indicator of injury than their systemic counterparts. 25, 26 Since there are contradicting studies on whether uRBP/c can detect renal dysfunction at an early stage, 12, 27, 28 additional studies are needed to determine the usefulness of this marker in the diagnosis of early CKD.
Both uNGAL/c and uIgG/c demonstrated high within-dog CVs.
The high variability in normal dogs implies that to be a good clinical marker (i.e., to allow an accurate discrimination of health status), the difference between healthy and diseased dogs (e.g., CKD) needs to be bigger relative to markers with a small CV. NGAL is similar to RBP as a low MW protein marker of kidney disease but can also be synthesized by damaged tubular epithelial cells. 10 uNGAL/c is <6 μg/g in healthy dogs, which corroborates with the current study's overall mean. 10 Only one dog had an uNGAL concentration below the LOD. Withindog CV of this longitudinal study also corroborates with high day-today biological variation of uNGAL/c in humans (CV ranging from 75% to 101%). [29] [30] [31] Variation from samples collected repeatedly within the same day is higher than between days. 32 The reason for this high variation is currently unknown. It should be highlighted that urinary levels in healthy dogs were 1000-fold lower than for the other two markers, uRBP and uIgG. To that extent, uNGAL/c might still have potential to detect early CKD, provided that the rise in concentration is high enough despite the high variation in healthy dogs. However, its ability to diagnose early CKD is still requires investigation as during early stages of canine X-linked hereditary nephropathy, when GFR is decreasing from >3.5 to 1.5-2.5 mL/min/kg, uNGAL/c increases 2-fold and then plateaus as GFR continues to decrease.
12
Immunoglobulin G is a high MW protein (150 kDa) that plays a part in the humoral immune system. 23 uIgG/c is increased in dogs with CKD and is positively correlated to glomerular lesions. 12, 13 Moreover, it is increased in early stages of CKD related to X-linked hereditary nephropathy in dogs. 12 The overall mean of uIgG/c from the current study was slightly higher than the observed maximum of 10 mg/g from healthy dogs in other studies. 10 Factors that affect uIgG concentrations in healthy dogs are still undetermined. Moreover, biological variation of uIgG/c in either humans or in other companion animal species than dogs has not been investigated. One possible explanation for the variation is that uIgG/c is significantly correlated to UPC. 12 In our study, a dog with mild proteinuria after the start of the study but was otherwise healthy had higher but relatively stable uIgG/c compared to other dogs. Despite the proteinuria, we chose to keep the dog in the study. Other than an increase in UPC between week 0 and week 12 (i.e., from 0.25 to 0.72), it fluctuated between 0.42 and 0.80 in the current study. According to Nabity and colleagues, for UPC values near 0.5, UPC must change by at least 80% before a change can be considered significant and warrant further investigation. 33 For UPC values starting at <0.2 or borderline proteinuria, as with the dog in our study, guidelines have not been proposed nor investigated. Moreover, this study was based on dogs with glomerular proteinuria caused by X-linked hereditary nephropathy, and whether this guideline can be applied to other glomerular diseases is still unknown. 33 Although this dog's proteinuria could be age-related as this dog was eight years at the start of the study, data linking proteinuria to aging in dogs is limited. 34 Future studies need to determine the age effect, as well as other factors on uIgG/c.
In accordance with the majority of other studies of markers of kidney disease in dogs that included a healthy control group, dogs in our study also had uCRP concentrations below the detection limit. 11, 17, 18, [35] [36] [37] [38] [39] CRP is a major positive acute phase protein in dogs with a large MW (110 to 144 kDa) and therefore is unable to pass through an intact glomerular barrier, which probably was the case in the healthy dogs in our study. 10 Further investigation into uCRP as a marker to detect the presence of glomerular injury is still warranted.
Although hematuria could potentially interfere with accurate determination of urinary analyte concentrations, its influence on uRBP/c, uIgG/c and uCRP/c seems to be limited. 35, 40 Furthermore, in the current study, hematuria was microscopic, most likely due to contamination from the cystocentesis, and only present in a small portion of the samples. Hence, the effect of hematuria on our results was negligible.
Because the dogs used in our study were from the same breed, kept in the same environment and were fed the same diet, the results of the current study cannot be applied to the general population of dogs. Therefore, studies in a large mix-breed population are required.
In such studies, the contribution of breed, sexual status, and age to the variation of biomarkers can also be assessed as to determine whether separate reference ranges are necessary. Furthermore, it would be interesting to determine, especially for the biomarkers with low within-dog variation, the change in concentration needed before it can be considered as indicative of disease.
In conclusion, markers of kidney disease sCysC, uRBP/c, uNGAL/c and uIgG/c show a wide range of intra-individual variation in healthy dogs, which might affect their interpretation. sCysC had the lowest variation, while the other markers exhibited large variation.
Clinically, if there is only a slight difference in concentration between healthy dogs and dogs with CKD, a value indicative of disease will likely be difficult to detect with the latter three markers, while the former might still be able to discriminate between dogs with or without renal damage. In other words, to be of added diagnostic value, the difference between healthy dogs and dogs with CKD would have to be considerable for uRBP/c, uNGAL/c and uIgG/c. While this study 
